Levi Strauss names Burberry exec Gianluca Flore its chief commercial officer
By Ben Glickman
Levi Strauss (LEVI) on Thursday named Burberry executive Gianluca Flore chief commercial officer as the company looks to round out its reshuffled leadership team.
The San Francisco-based jeans maker said Flore would report to Chief Executive Michelle Gass and oversee the company's commercial operations across stores, e-commerce and wholesale. His appointment is effective July 29.
Flore, 53, was appointed chief commercial officer of Burberry (UK:BRBY) in 2021, and earlier served as president for the Americas and global retail excellence at the company. He has also held positions at Kering, and was CEO of Brioni.
Levi's said in a regulatory filing that Flore would receive a base salary of $1 million per year, and will have an initial target bonus of 100% of his salary.
Flore is the latest executive appointment made by Gass. In January, she added Levi's chief marketing officer and chief merchandising officer to the executive leadership team and said the company was looking to hire a new president and CCO.
Gass was joined Levi's in January 2023 as president, and was named CEO in December. She joined the company from Kohl's.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-11-24 1852ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks